BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34230493)

  • 21. Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Pomeroy EJ; Lee LA; Lee RDW; Schirm DK; Temiz NA; Ma J; Gruber TA; Diaz-Flores E; Moriarity BS; Downing JR; Shannon KM; Largaespada DA; Eckfeldt CE
    Oncogene; 2017 Jun; 36(23):3263-3273. PubMed ID: 27991934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice.
    Schessl C; Rawat VP; Cusan M; Deshpande A; Kohl TM; Rosten PM; Spiekermann K; Humphries RK; Schnittger S; Kern W; Hiddemann W; Quintanilla-Martinez L; Bohlander SK; Feuring-Buske M; Buske C
    J Clin Invest; 2005 Aug; 115(8):2159-68. PubMed ID: 16025155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent juvenile myelomonocytic leukemia and T-lymphoblastic lymphoma with a shared missense mutation in NRAS.
    Ly B; Modi A; Rogers HJ; Makishima H; Hanna R; Cook JR; Theil KS; Maciejewski JP
    Pediatr Blood Cancer; 2014 May; 61(5):946-8. PubMed ID: 24610751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Convergence of oncogenic cooperation at single-cell and single-gene levels drives leukemic transformation.
    Liu Y; Gu Z; Cao H; Kaphle P; Lyu J; Zhang Y; Hu W; Chung SS; Dickerson KE; Xu J
    Nat Commun; 2021 Nov; 12(1):6323. PubMed ID: 34732703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage-specific action of Runx1 and GATA3 controls silencing of PU.1 expression in mouse pro-T cells.
    Hosokawa H; Koizumi M; Masuhara K; Romero-Wolf M; Tanaka T; Nakayama T; Rothenberg EV
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34180951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Miltefosine suppression of Pten null T-ALL leukemia via β-catenin degradation through inhibition of pT308-Akt and TGFβ1/Smad3.
    Zhang Y; Lee S; Xu W
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1018-1024. PubMed ID: 32063363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B.
    Batista CR; Lim M; Laramée AS; Abu-Sardanah F; Xu LS; Hossain R; Bell GI; Hess DA; DeKoter RP
    Blood Adv; 2018 Nov; 2(21):2798-2810. PubMed ID: 30355579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
    Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
    Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.
    Raikar SS; Scarborough JD; Sabnis H; Bergsagel J; Wu D; Cooper TM; Keller FG; Wood BL; Bunting ST
    Pediatr Blood Cancer; 2016 Sep; 63(9):1667-70. PubMed ID: 27145535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system.
    Bornschein S; Demeyer S; Stirparo R; Gielen O; Vicente C; Geerdens E; Ghesquière B; Aerts S; Cools J; de Bock CE
    Leukemia; 2018 Apr; 32(4):941-951. PubMed ID: 29151585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional regulation of CD4 gene expression by T cell factor-1/beta-catenin pathway.
    Huang Z; Xie H; Ioannidis V; Held W; Clevers H; Sadim MS; Sun Z
    J Immunol; 2006 Apr; 176(8):4880-7. PubMed ID: 16585583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.
    Dorfman DM; Greisman HA; Shahsafaei A
    Am J Pathol; 2003 May; 162(5):1539-44. PubMed ID: 12707037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of a Tetracycline Regulated Mouse Model of MYC-Induced T-Cell Acute Lymphoblastic Leukemia.
    Mahauad-Fernandez WD; Rakhra K; Felsher DW
    Methods Mol Biol; 2021; 2318():297-312. PubMed ID: 34019298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis.
    Carr RM; Vorobyev D; Lasho T; Marks DL; Tolosa EJ; Vedder A; Almada LL; Yurcheko A; Padioleau I; Alver B; Coltro G; Binder M; Safgren SL; Horn I; You X; Solary E; Balasis ME; Berger K; Hiebert J; Witzig T; Buradkar A; Graf T; Valent P; Mangaonkar AA; Robertson KD; Howard MT; Kaufmann SH; Pin C; Fernandez-Zapico ME; Geissler K; Droin N; Padron E; Zhang J; Nikolaev S; Patnaik MM
    Nat Commun; 2021 May; 12(1):2901. PubMed ID: 34006870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia.
    Al-Kzayer LF; Sakashita K; Al-Jadiry MF; Al-Hadad SA; Ghali HH; Uyen le TN; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Sughayer MA; Rihani R; Madanat FF; Inoshita T; Kamata M; Koike K
    Pediatr Blood Cancer; 2015 Dec; 62(12):2157-61. PubMed ID: 26222068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
    Sanda T; Leong WZ
    Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia.
    Rimmelé P; Esposito M; Delestré L; Guervilly JH; Ridinger-Saison M; Despras E; Moreau-Gachelin F; Rosselli F; Guillouf C
    Oncotarget; 2017 Jun; 8(23):37104-37114. PubMed ID: 28415748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
    Shi X; Yang Y; Shang S; Wu S; Zhang W; Peng L; Huang T; Zhang R; Ren R; Mi J; Wang Y
    BMC Cancer; 2019 Nov; 19(1):1072. PubMed ID: 31703632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement for a nuclear function of beta-catenin in Wnt signaling.
    Cong F; Schweizer L; Chamorro M; Varmus H
    Mol Cell Biol; 2003 Dec; 23(23):8462-70. PubMed ID: 14612392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.